Indications And Dose
Treatment of postmenopausal osteoporosis in women at risk of vitamin D deficiency ▶BY MOUTH ▶Adult (female): 1 tablet once weekly.
PDF page 789
Loading InternPractice…
Drug reference
Treatment of postmenopausal osteoporosis in women at risk of vitamin D deficiency ▶BY MOUTH ▶Adult (female): 1 tablet once weekly.
PDF page 789
→Appendix 1: bisphosphonates. vitamin D substances
PDF page 789
Tablets should be swallowed whole with plenty of water while sitting or standing; to be taken on an empty stomach at least 30 minutes before breakfast (or another oral medicine); patient should stand or sit upright for at least 30 minutes after taking tablet.
PDF page 789
There can be variation in the licensing of different medicines containing the same drug. Tablet ▶Alendronic acid with colecalciferol (Non-proprietary) Colecalciferol 70 microgram, Alendronic acid (as Alendronate sodium) 70 mg Alendronic acid 70mg / Colecalciferol 70microgram tablets | 4 tablet P £22.80 DT = £22.80 ▶Bentexo (Consilient Health Ltd) Colecalciferol 140 microgram, Alendronic acid (as Alendronate sodium) 70 mg Bentexo 70mg/5,600unit tablets | 4 tablet P £4.25 ▶Fosavance (Merck Sharp & Dohme Ltd) Colecalciferol 70 microgram, Alendronic acid (as Alendronate sodium) 70 mg Fosavance tablets | 4 tablet P £22.80 DT = £22.80 eiiii F 765
PDF page 789
Patients or carers should be given advice on how to administer alendronic acid with colecalciferol tablets.
PDF page 789
1 tablet once weekly.
First-line fragment. Read the complete Indications and Dose section above.
PDF page 789